Welcome There!
Galderma Hong Kong Limited (hereinafter referred to as GALDERMA), a medically certified pioneer in aesthetics, boasts over 20 years of research experience and has successfully marketed its products in more than 100 countries, earning the trust of over 85 million users worldwide1.
As a science-driven company, we have conducted the most extensive clinical research and published hundreds of scientific papers, dedicated to providing effective solutions for maintaining healthy skin for the general public. All Galderma products are manufactured in Europe and are approved by both the U.S. Food and Drug Administration (FDA) and the European Union (CE). They come with dual original authenticity certification and are accompanied by accredited training courses provided to qualified medical practitioners, with certificates issued every six months to ensure product and treatment quality.
1. Data on file (MA-39680).; Data on file (MA-40221).; Data on file (MA-39613).
Our Products
US FDA-approved, highly purified botulinum toxin type A effectively relaxes overcontracted muscles, smoothing wrinkles and fine lines. It offers natural-looking1 results that can last up to 5 months2, with a satisfaction rate of 98%1.
1. Schlessinger J et al. Dermatol Surg, 2021;47(4): 504-509
2. Kassir R et al. Dermatol Ther. 2013;3(2):179–189.
The world’s first non-animal stabilized hyaluronic acid filler, featuring our exclusive patented NASHA® and OBTTM series1-3, allows you to tailor your contour to your individual needs.
1. Belmontesi M, De Angelis F, Di Gregorio C, et al. J Drugs Dermatol. 2018;17(1):83-88.
2. Reuther T, Bayrhammer J, Kerscher M. Arch Dermatol Res. 2010;302:37-45.
3. Streker M, Reuther T, Krueger N, et al. J Drugs Dermatol. 2013;12:990-994.
The only skin hydration solution that provides six key benefits1-8 and lasts up to 15 months9-10.
1. Dierickx C, et al. Dermatol Surg 2018;44 Suppl 1:S104–S18Gubanova E, et al. J Drugs Dermatol 2015;14(3):288–298.
2. Kerscher M, et al. Dermatol Surg 2008;34(5):720–726.
3. Kim J. Arch Aesthetic Plast Surg 2014;20(2):97–103.
4. Lee B, et al. Arch Plast Surg 2015;42(3):282–287.
5. Ribé A, et al. J Cosmet Laser Ther 2011;13(4):154–161.
6. Williams S, et al. J Cosmet Dermatol 2009;8(3):216–225.
7. Wu Y, et al. J Cosmet Dermatol 2020;19(7):1627–1635.
8. Belmontesi M, De Angelis F, Di Gregorio C, et al. J Drugs Dermatol. 2018;17(1):83-88.
9. Wu Y, et al. J Cosmet Dermatol 2020;19(7):1627–1635
* Summary of Safefy and Effectiveness data. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf3/p030050s002b.pdf Accessed August 2021.
1. Goldberg D, et al. Dermatol Surg. 2013:39(6):915-922.
2. Narin RS, et al. J Am Acad Dermatol. 2010; 62(3):448-462.
3. Brandt FS, et al. Aesthet Surg J. 2011; 31(5):521-528.